Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
6.02
+0.02 (0.33%)
At close: Dec 5, 2025, 4:00 PM EST
6.02
0.00 (0.00%)
After-hours: Dec 5, 2025, 6:43 PM EST
Coya Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Coya Therapeutics stock have an average target of 15.8, with a low estimate of 14 and a high estimate of 18. The average target predicts an increase of 162.46% from the current stock price of 6.02.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Coya Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +132.56% | Nov 14, 2025 |
| BTIG | BTIG | Strong Buy Maintains $15 → $16 | Strong Buy | Maintains | $15 → $16 | +165.78% | Nov 13, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +149.17% | Nov 12, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +149.17% | Sep 30, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $18 | Strong Buy | Maintains | $18 | +199.00% | Sep 29, 2025 |
Financial Forecast
Revenue This Year
6.71M
from 3.55M
Increased by 88.66%
Revenue Next Year
102.00K
from 6.71M
Decreased by -98.48%
EPS This Year
-1.20
from -0.98
EPS Next Year
-1.51
from -1.20
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 9.3M | 420,000 | ||||
| Avg | 6.7M | 102,000 | ||||
| Low | 3.9M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 162.4% | -93.7% | ||||
| Avg | 88.7% | -98.5% | ||||
| Low | 9.9% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.04 | -1.35 | ||||
| Avg | -1.20 | -1.51 | ||||
| Low | -1.33 | -1.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.